3[1]Muramatsu K, Maitani Y, Nagai T. Dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols and cholesterol as a carrier for the oral administration of insulin in rats [J]. Biol Pharm Bull, 1996, 19(8):1055-1058.
4[2]Choudhari KB, Labhasetwar V, Dorle AK. Liposomes as a carrier for oral administration of insulin: effect of formultion factors [J]. J Microencapsulation, 1994, 11(3):319-325.
5[3]Aspden TJ, Mason JDT, Jones NS, et al. Chitosan as a nasal delivery system: The effect of chitosan solutions on in vitro and in vivo mucocilliary transport rates in human turbinates and volunteers [J]. J Pharm Sci, 1997, 86(4):509-513.
6[4]Henriksen I, Vagen SR, Sande SA, et al. Interaction brtween liposomes and chitosan II: effect of selected parameters on aggregation and leakage [J]. Int J PHarm, 1997, 146:193-204.
7[5]Lehr C, Bouwstra JA, Schacht EA, et al. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers [J]. Int J PHarm, 1992, 78:43-48.
8[6]He P, Davis SS, Illum L. In vitro evaluation of mucoadhesive properties of chitosan microspheres [J]. Int J Pharm, 1998, 166:75-88.
9[7]Schipper NGM, Olsson S, Hoogstraate JA, et al. Chitosans as absorption enhancers for poorly absorbable drug 2: Mechanism of absorption enhancement [J]. Pharm Res, 1997, 14(7):923-929.
10[8]Dung PL, Milas M, Rinaudo M, et al. Water soluble derivatives obtained by controlled chemical modifications of chitosan [J]. Carbohyd Polym, 1994, 24:209-214.
